MedTrace Logo

OCS Liver DCD Trial

NCT04194437 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2025-09-05

Study results available
· View outcomes & findings →

Summary

Evaluate the safety and effectiveness of the OCS Liver System to preserve, optimize the condition, and assess levers from DCD donors.

Conditions

  • Liver Transplant

Interventions

DEVICE

OCS Liver System

The OCS Liver System will be used to preserve, optimize and assess livers from DCD donors.

Sponsors & Collaborators

  • TransMedics

    lead INDUSTRY

Principal Investigators

  • Ahmed Elbetanony, MD · TransMedics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-24
Primary Completion
2022-03-22
Completion
2024-12-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04194437 on ClinicalTrials.gov